Update on JAMA's conflict of interest policy

JAMA

Volumn 296, Issue 2, 2006, Pages 220-221

  Flanagin, Annette ^a   Fontanarosa, Phil B ^a   DeAngelis, Catherine D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; CONFLICT OF INTEREST; EDITORIAL; HUMAN; MEDICAL LITERATURE; POLICY; PRIORITY JOURNAL;

EID: 33745901304     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.2.220     Document Type: Editorial

References (15)

1. Lundberg GD, Flanagin A. New requirements for authors: signed statements of authorship responsibility and financial disclosure. JAMA. 1989;262:2003-2004.
2. Rennie D, Flanagin A, Glass RM. Conflicts of interest in the publication of science. JAMA. 1991;266:266-267.
3. DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA. 2001;286:89-91.
4. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294:110-111.
5. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: updated October 2005. http://www.icmje.org. Accessibility verified June 15, 2006.
6. Council of Science Editors. Conflicts of interest and the peer review process. http://www.councilscienceeditors.org/services/draft_approved.cfm. Accessibility verified June 15, 2006.
7. World Association of Medical Editors. WAME recommendations on publication ethics policies for medical journals. http://www.wame.org/pubethicrecom.htm. Accessibility verified June 15, 2006.
8. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics. 2001;7:205-218.
9. Ancker J, Flanagin A. A comparison of conflict of interest policies at peerreviewed journals in multiple scientific disciplines. Paper presented at: The Fifth International Congress on Peer Review and Biomedical Publication; September 17, 2005; Chicago, Ill. http://www.ama-assn.org/public/peer/program. html. Accessed June 13, 2006.
10. Incorrect statements on funding/support and role of the sponsors and incorrect and incomplete financial disclosures [published correction online May 16, 2006]. JAMA. 2006;295:2482. http://jama.ama-assn.org/cgi/content/full/295/ 21/2482-c. Accessed June 13, 2006.
11. Ridker PM. Incomplete financial disclosure for study of funding and outcomes in major cardiovascular trials [letter]. JAMA. 2006;295:2725-2726.
12. Incomplete financial disclosure [correction]. JAMA. 2006;295:2726.
13. Cohen LS, Nonacs R, Viguera AC, et al. Antidepressant treatment and relapse of depression during pregnancy [letter]. JAMA. 2006;296:165-167.
14. Incomplete financial disclosure [correction]. JAMA. 2006;296:170.
15. Instructions for authors. JAMA. 2006;296:107-116.